119 related articles for article (PubMed ID: 16253793)
1. Putting the cart before the horse: a cautious look at the role of IgM-enriched polyclonal immunoglobulin in sepsis therapy.
Shafazand S; Colice G
J Crit Care; 2005 Sep; 20(3):249-50. PubMed ID: 16253793
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.
Neilson AR; Burchardi H; Schneider H
J Crit Care; 2005 Sep; 20(3):239-49. PubMed ID: 16253792
[TBL] [Abstract][Full Text] [Related]
3. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
Berlot G; Dimastromatteo G
Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
[TBL] [Abstract][Full Text] [Related]
4. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
Neugebauer EA
Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
[No Abstract] [Full Text] [Related]
5. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
6. The costs and cost-effectiveness of an integrated sepsis treatment protocol.
Talmor D; Greenberg D; Howell MD; Lisbon A; Novack V; Shapiro N
Crit Care Med; 2008 Apr; 36(4):1168-74. PubMed ID: 18379243
[TBL] [Abstract][Full Text] [Related]
7. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
8. Mirror, mirror on the wall, which is the fairest meta-analysis of all?
Werdan K
Crit Care Med; 2007 Dec; 35(12):2852-4. PubMed ID: 18043202
[No Abstract] [Full Text] [Related]
9. Effect of IgM-Enriched Immunoglobulin as Adjunctive Therapy in a Patient Following Sepsis After Open Thoracoabdominal Aortic Aneurysm Repair.
Kukic BP; Savic NB; Stevanovic KS; Trailovic RDj; Cvetkovic SD; Davidovic LB
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):746-8. PubMed ID: 26708694
[No Abstract] [Full Text] [Related]
10. [Immunoglobulin therapy of postoperative sepsis].
Wesoly C; Kipping N; Grundmann R
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):213-6. PubMed ID: 2095647
[TBL] [Abstract][Full Text] [Related]
11. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
12. [Use of immunoglobulin enriched with class IgM antibodies in treatment of purulent meningitis].
Szenborn L; Rudowski Z
Pol Tyg Lek; 1994 May 16-30; 49(20-22):465-7. PubMed ID: 7651916
[No Abstract] [Full Text] [Related]
13. Monoclonal antibodies in sepsis and septic shock.
Hinds CJ
BMJ; 1992 Jan; 304(6820):132-3. PubMed ID: 1571053
[No Abstract] [Full Text] [Related]
14. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
[TBL] [Abstract][Full Text] [Related]
15. Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study.
Toth I; Mikor A; Leiner T; Molnar Z; Bogar L; Szakmany T
J Anesth; 2013 Aug; 27(4):618-22. PubMed ID: 23314695
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
Wilson SJ; Mehta SS; Bellamy MC
Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.
Soares MO; Welton NJ; Harrison DA; Peura P; Shankar-Hari M; Harvey SE; Madan J; Ades AE; Rowan KM; Palmer SJ
Crit Care; 2014 Dec; 18(6):649. PubMed ID: 25434816
[TBL] [Abstract][Full Text] [Related]
19. Treatment with IgM-enriched immunoglobulin in sepsis: a matched case-control analysis.
Martinez JI; Sánchez HF; Velandia JA; Urbina Z; Florián MC; Martínez MA; Giamarellos-Bourboulis EJ; Pino-Pinzón CJ; Ortiz G; Celis E
J Crit Care; 2021 Aug; 64():120-124. PubMed ID: 33872918
[TBL] [Abstract][Full Text] [Related]
20. Sepsis and septic shock: selection of empiric antimicrobial therapy.
Cunha BA
Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
